Hycamtin

Active Ingredient(s): Topotecan
FDA Approved: * May 28, 1996
Pharm Company: * GLAXOSMITHKLINE
Category: Cancer

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Hycamtin Overview

Topotecan (trade name Hycamtin) is a chemotherapeutic agent that is a topoisomerase inhibitor. It is a synthetic, water-soluble analog of the natural chemical compound camptothecin. It is used in the form of its hydrochloride salt to treat ovarian cancer, lung cancer and other cancer types. After GlaxoSmithKline received final FDA approval for Hycamtin Capsules on October 15, 2007, topotecan became the first topoisomerase I inhibitor for oral use. Contents 1 Uses 1.1 Experimental uses 1...

Read more Hycamtin Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Topotecan

Recent Hycamtin Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Topotecan
  • Capsule: 0.25mg, 1mg
  • Injection: 1.5mg, 1mg/ml, 3mg/3ml, 4mg/4ml, 4mg/vial
  • Solution: 1mg/ml (1mg/ml), 3mg/3ml (1mg/ml), 4mg/4ml (1mg/ml)
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Hycamtin: (9 results)

Sorted by National Drug Code
  • 0007-4201 Hycamtin 4 mg/4ml Intravenous Injection, Powder, Lyophilized, for Solution by Glaxosmithkline LLC
  • 0007-4205 Hycamtin 0.25 mg Oral Capsule by Glaxosmithkline LLC
  • 0007-4207 Hycamtin 1 mg Oral Capsule by Glaxosmithkline LLC
  • 0078-0672 Hycamtin .25 mg Oral Capsule by Novartis Pharmaceuticals Corporation
  • 0078-0673 Hycamtin 1 mg Oral Capsule by Novartis Pharmaceuticals Corporation
  • 0078-0674 Hycamtin 4 mg/4ml Intravenous Injection, Powder, Lyophilized, for Solution by Novartis Pharmaceuticals Corporation
  • 12064-000 Hycamtin .25 mg Oral Capsule by Glaxosmithkline Manufacturing Spa
  • 12064-001 Hycamtin 1 mg Oral Capsule by Glaxosmithkline Manufacturing Spa
  • 12064-002 Hycamtin 4 mg/4ml Intravenous Injection, Powder, Lyophilized, for Solution by Glaxosmithkline Manufacturing Spa

Other drugs which contain Topotecan or a similar ingredient: (1 result)




Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 16 October 2019.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA